Adimmune (TPE:4142) OCF Margin %: 110.93% (As of Dec. 2025)


TPE:4142 Adimmune Corp TPE:4142
55 GF Score
Price NT$16.80
GF Value NT$25.40
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Adimmune OCF Margin %?

Adimmune TPE:4142 -1.75% 55 OCF Margin % is 110.93% as of Dec. 2025. GuruFocus rates TPE:4142 with a GF Score™ of 55/100 and a GF Value™ of NT$25.40 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Adimmune ranks better than 68.2% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Adimmune's Cash Flow from Operations for the three months ended in Dec. 2025 was NT$827 Mil. Adimmune's Revenue for the three months ended in Dec. 2025 was NT$745 Mil. Therefore, Adimmune's OCF Margin % for the quarter that ended in Dec. 2025 was 110.93%.

As of today, Adimmune's current OCF Yield % is -0.07%.

The historical rank and industry rank for Adimmune's OCF Margin % or its related term are showing as below:

TPE:4142' s OCF Margin % Range Over the Past 10 Years
Min: -127.49   Med: -16.21   Max: 124.21
Current: -0.39


During the past 13 years, the highest OCF Margin % of Adimmune was 124.21%. The lowest was -127.49%. And the median was -16.21%.

TPE:4142's OCF Margin % is ranked better than
68.2% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs TPE:4142: -0.39


Adimmune OCF Margin % Related Terms


Adimmune OCF Margin % Historical Data

* Premium members only.

The historical data trend for Adimmune's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adimmune OCF Margin % Chart

Adimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.79 -12.97 -49.99 42.93 -0.39

Adimmune Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.78 -293.91 -244.35 -74.70 110.93

TPE:4142 vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Adimmune's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adimmune OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adimmune's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Adimmune's OCF Margin % falls into.


TPE:4142
55GF Score
Adimmune Corp TPE:4142
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adimmune OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Adimmune's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-5.446/1401.501
=-0.39 %

Adimmune's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=826.953/745.462
=110.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 110.93% mean?
Adimmune (TPE:4142) has a OCF Margin % of 110.93% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Adimmune and its competitors. According to the industry distribution chart, Adimmune ranks #305 out of 959 companies in the Biotechnology industry, placing it in the top 31.8%.
Is Adimmune's OCF Margin % too high?
Adimmune's current OCF Margin % is 110.93%. Based on the distribution chart, Adimmune ranks #305 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Adimmune has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adimmune's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Adimmune ranks #305 out of 959 companies for OCF Margin %. This puts Adimmune in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Adimmune and its competitors. Adimmune's current OCF Margin % is 110.93%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adimmune stock overvalued right now?
Based on GuruFocus' analysis, Adimmune (TPE:4142) is currently considered Possible Value Trap. The stock's GF Value™ is NT$25.40, compared to a current price of NT$16.80 — trading 33.9% below its estimated fair value. The current OCF Margin % is 110.93%. Adimmune's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Adimmune (TPE:4142), the current OCF Margin % is 110.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$16.80 is trading 33.9% below its estimated GF Value™ of NT$25.40. GuruFocus considers Adimmune to be Possible Value Trap.

Key valuation signals for TPE:4142:

  • OCF Margin %: 110.93%
  • GF Value™: NT$25.40 vs. price of NT$16.80 (33.9% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
55GF Score

Get the complete analysis for TPE:4142

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.80
Price
NT$25.40
GF Value